round 2 of the canada: rapid response 2016 program is now open. this program provides seed funding for novel, high-risk, high-reward translational research. this round of the program will focus on parkinson’s and related diseases. applications for round 2 will close tuesday, july 5^th at 1:00 p.m. edt.

program goal

provide seed funding for novel, high-risk, high-reward translational research ideas to catalyze the development of safe and effective treatments for neurodegenerative diseases of aging

the primary objective of this funding opportunity is to bring together multiple stakeholder groups from across canada to form a national, clinical research network that will provide the infrastructure and support for an integrated and collaborative effort to improve the outcomes of preterm birth across the continuum of perinatal, neonatal, and developmental care. the goal of this network will be to translate existing and new knowledge generated by clinical, quality improvement, and health services research into pan-canadian practices and policies that lead to transformative and measurable improvements in the short and long-term outcomes of preterm infants.

specifically, network applicants will be expected to show that the planned national network infrastructure, partnerships, and synergies can support a program of research and knowledge translation that will:

• develop, implement, and evaluate transformational approaches to improving infant outcomes along the continuum of perinatal, neonatal, and developmental care that:
  • are national in scope; and
  • have a measurable impact within the 5-year timeframe of the grant.
• strengthen perinatal and neonatal clinical research efforts to improve patient outcomes, including practice and policy change and systems improvement.
• develop, implement, and evaluate better early development, educational, and social interventions aimed at improving long-term patient outcomes.
• support research into the costs of preterm birth and the efficiencies achieved by the network activities.
• ensure research results and practice and policy changes are effectively implemented on a national scale across sectors.
• foster an interdisciplinary research culture focused on quality improvement.
• develop a cadre of early and mid-career researchers with expertise in improving the outcomes of preterm birth.

in addition, network applicants should develop an approach that is family-centred and works to integrate services across the continuum of perinatal, neonatal, and developmental care. international collaborations that strengthen the research conducted, as well as promote canadian research on a global scale, are also encouraged.

the specific objectives of this funding opportunity, as defined in the horizon 2020 call are to:

• translate big data and basic research results into clinical applications.
• contribute to exploiting data from ihec and, as appropriate, data from other international initiatives.
• identify and select new biomarkers for clinical validation in stratified patient populations
• develop new targeted therapies for diseases of the immune system with high prevalence.
• in line with the european union's strategy for international cooperation in research and innovation, proposals should create strategic synergies between scientists across disciplines, sectors and around the globe.

the specific objective of this funding opportunity is to support cross-jurisdictional teams of researchers and knowledge users to produce knowledge syntheses or scoping reviews relevant to the priorities of the primary and integrated health care innovations (pihci) network that will contribute to the use of synthesized evidence in decision-making and practice across multiple jurisdictions.

relevant research areas

priorities have been determined in consultation with the pihci member networks and partners. a high-level summary of priorities is found below. full descriptions of all relevant research areas can be found in a separate document that has been shared with the member networks. applicants must demonstrate how the proposed project responds to one or more of the following priorities:

• innovation in integrated service delivery models that meet the needs of individuals with complex needs
• ehealth innovations that improve person-centered, appropriate and integrated care
• identifying individuals with complex needs and understanding their needs
• integrating health promotion/disease prevention in care delivery models to prevent future needs for complex care
• priority populations: individuals with multi-morbidity; frail seniors; mental illness
• patient’s role in maintaining their health: patient literacy
• supporting healthy aging and the needs of older adults through primary and integrated models of care
• outcome/value-based funding models that incentivize integration across the continuum of care
• understanding outcomes that should be prioritized (e.g., healthy patients vs. happy patients)

n.b.: it is also strongly recommended that applicants interested in applying to this funding opportunity consult with the relevant member networks prior to conceptualizing an application.

in the context of improved health for canadians, the objectives of collaborative health research projects (chrp) initiative are to:

• translate research results to knowledge/technology users and other stakeholders;
• encourage the natural sciences or engineering and health research communities to collaborate and integrate their expertise;
• advance interdisciplinary research leading to knowledge and technologies with the potential to benefit canada by improving the canadian healthcare system and/or services and where appropriate lead to economic opportunities in canada; and
• train highly qualified personnel in collaborative and interdisciplinary research of relevance to health, while preparing them for employment opportunities in the private, public or not for profit sectors.

the specific objectives of this funding opportunity are:

• to provide salary support for up to six years to clinician scientists.
• to provide a reliable supply of highly skilled and qualified clinician scientists.

the specific objectives of this funding opportunity are to:

• support exploratory, blue-sky and high-risk research projects with the potential for high impact, breakthrough and/or transformative advances;
• support novel and untried approaches to preterm birth research;
• encourage preterm birth researchers to collaborate with partners working in non-traditional fields such as physics, imaging, mathematics, computing and nanotechnology.

funding opportunities for fiscal year 2016 (fy16)

the fy16 defense appropriations act provides $12 million (m) to the department of defense (dod) lung cancer research program (lcrp) to support innovative, high-impact lung cancer research.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency, research, development, and acquisition directorate manages the defense health program research, development, test, and evaluation appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp).

fy16 lcrp program announcements and general application instructions for the following award mechanisms are posted on the grants.gov.

areas of emphasis:  the fy16 lcrp encourages research projects that specifically address the critical needs of the lung cancer community in the following areas of emphasis:

•       identify or develop noninvasive or minimally invasive tools to improve the detection of the initial stages of lung cancer.

•       identify, develop, and/or build upon already existing tools for screening or early detection of lung cancer.  screening may include, but is not limited to, imaging modalities, biomarkers, genetics/genomics/proteomics/metabolomics/transcriptomics, and assessment of risk factors.

•               understand the molecular mechanisms of initiation and progression to clinically significant lung cancer.

•               identify innovative strategies for prevention and treatment of early and/or localized lung cancer.

•       understand predictive and prognostic markers to identify responders and nonresponders.

•       understand susceptibility or resistance to treatment.

•       understand contributors to lung cancer development other than tobacco.

military relevance:  the fy16 lcrp strongly encourages research projects that are relevant to the health care needs of military service members, veterans, and their families.  investigators are encouraged to consider the following characteristics as examples of how a project may demonstrate military relevance:

•       use of military or veteran populations or data in the proposed research.

•       collaboration with dod or department of veterans affairs investigators.

•       involvement of military consultants (army, air force) or specialty leaders (navy, marine corps) to the surgeons general in a relevant specialty area.

•       description of how the knowledge, information, products, or technologies gained from the proposed research could be implemented in a dual-use capacity to address a military need that also benefits the civilian population.

•       explanation of how the project addresses an aspect of lung cancer that has direct relevance to military service members, veterans, or other military health system beneficiaries, including environmental exposures other than tobacco.

http://cdmrp.army.mil/funding/lcrp.shtml

career development award – preproposal due 6.9.16

principal investigator:  independent investigators at the level of assistant professor, instructor, or equivalent; must be within 5 years of first faculty appointment

mentor:  at or above the level of associate professor (or equivalent); have a proven publication and funding record in lung cancer research

supports early-career, independent researchers to conduct research under mentorship of an experienced lung cancer researcher

clinical trials not allowed

preliminary data not required

military relevance strongly encouraged

maximum funding of $250,000 in direct costs (plus indirect costs)

period of performance should not exceed 2 years

clinical exploration award– preproposal due 6.9.16

independent investigators at or above the level of assistant professor (or equivalent)

supports rapid execution of hypothesis-driven, early-phase clinical trials to examine interventions that could have a major impact on lung cancer clinical management.  it is anticipated that proposed studies will explore innovative and untested concepts to provide scientific rationale or initial proof-of-principle for larger clinical trials in lung cancer

the application must include documentation of an existing investigational new drug (ind) or investigational device exemption, if applicable

the proposed study is expected to begin no later than 12 months after the award date

military relevance strongly encouraged

maximum funding of $550,000 in direct costs (plus indirect costs)

period of performance should not exceed 3 years

idea development award– preproposal due 6.9.16

established investigators:  independent investigators at or above the level of assistant professor (or equivalent); or

new investigators:  investigators that meet the following criteria at the application submission deadline date:

have not previously received a lcrp idea development award or early investigator synergistic idea award

independent investigators at or above the level of assistant professor (or equivalent) and be within 10 years of first faculty appointment (or equivalent)

supports new ideas in the early stages of development representing innovative, high-risk/high-gain research

emphasis on innovation and impact

new investigator category supports applicants early in their faculty appointments or in the process of developing independent research careers

clinical trials not allowed

preliminary data required, but may be from outside lung cancer

military relevance strongly encouraged

maximum funding of $350,000 in direct costs (plus indirect costs)

period of performance should not exceed 2 years

investigator-initiated translational research award– preproposal due 6.9.16

independent investigators at or above the level of assistant professor (or equivalent)

supports translational research that will develop promising ideas in lung cancer into clinical applications.  translational research may be defined as an integration of basic science and clinical observations

this mechanism is intended to fund a broad range of translational studies, including, but not limited to, the following:

studies advancing/translating in vitro and/or animal studies to applications with human samples/cohorts.

late-stage preclinical work leading to/preparing for a clinical trial, e.g., ind submission.

correlative studies that are associated with an ongoing or completed clinical trial and projects that develop endpoints for clinical trials.

clinical trials not allowed

preliminary data required, but may be from outside lung cancer

military relevance strongly encouraged

maximum funding of $400,000 in direct costs (plus indirect costs)

period of performance should not exceed 2 years

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

applications must be submitted through the federal government’s single-entry portal, grants.gov.  for more information about the lcrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org

the banting postdoctoral fellowships program provides funding to the very best postdoctoral applicants, both nationally and internationally, who will positively contribute to the country's economic, social and research-based growth.

the objective of the banting postdoctoral fellowships program is to:

• attract and retain top-tier postdoctoral talent, both nationally and internationally
• develop their leadership potential
• position them for success as research leaders of tomorrow

features

the banting postdoctoral fellowships program is unique in its emphasis on the synergy between the following:

• applicant – individual merit and potential to launch a successful research-intensive career
• host institution – commitment to the research program and alignment with the institution's strategic priorities

an applicant to the banting postdoctoral fellowships program must complete their application in full collaboration with the proposed host institution.

• banting postdoctoral fellowships (although the banting deadline is september 21, 2016, applicants and their supervisors should contact research services (ahacquo1@lakeheadu.ca) far in advance of the deadline if they are submitting an application):  please note that for the purposes of your submission, 阿根廷vs墨西哥竞猜 is willing to make the following contributions:
  
  if you are successful with a banting, the vp (ri) will contribute a minimum of $5,000.  in addition, the vp (ri) will contribute an additional $2,500 if matched by an additional $2,500 from the respective faculty dean for a potential institutional contribution of $10,000.  the match from the dean must be requested by pdf supervisors and confirmed in writing.

cifar invites outstanding early-career researchers to join one of nine research programs which address some of the most complex challenges facing the world today. the cifar azrieli global scholars program provides funding and support to help you build your research network and develop essential skills at this important time in your career.

as a cifar azrieli global scholar, you’ll receive:

• a two-year appointment to a cifar research program
• $100,000 cdn in undesignated research support
• specialized leadership and communications training

scholars are appointed to a research program, becoming part of a global network of leading researchers pursuing answers to some of the most difficult challenges facing the world today. you’ll forge new collaborations with mentors and colleagues from diverse disciplines. experts will help you hone your leadership and communication skills to prepare you to be an influential leader within academia and beyond.

applications are submitted online through cifar’s application system. they must include three letters of recommendation from at least one faculty member or equivalent and preferably one non-academic leader.

the application will require you to answer questions about:

• your research and how it complements the cifar program you would like to join
• ideas for collaboration with fellows in the program
• your leadership experience to date
• your engagement with non-academic communities or interest in such engagement